Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2008
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/20/2008US20080287358 Regulatory T Cell Mediator Proteins and Uses Thereof
11/20/2008US20080287352 Anti-Histone H1 Monoclonal Antibody and Hybridoma for the Production Thereof
11/20/2008US20080286817 Novel allergens and treatment
11/20/2008US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286389 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/20/2008US20080286371 highly ordered nanostructured mesoporous silica, having size pores of 2 to 50 nm and antigens of several natures, encapsulated by the particles of mesoporous silica, which act as immunization adjuvants
11/20/2008US20080286353 Cationic liposomes containing immune response generating moieties
11/20/2008US20080286315 Methionine Enkephalin as an Adjuvant for Vaccine Immunizations
11/20/2008US20080286312 Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes
11/20/2008US20080286311 providing a wild-type protein allergen, splicing it into two parts that have a reduced allergenic activity or lacking allergenic activity and rejoining the two fragments in inverse orientation; allergy immunotherapy; low risk for anaphylactic shock; preparation of antiallergens
11/20/2008US20080286307 Two-Step Temperature Profile for the Propagation of Viruses
11/20/2008US20080286305 Transgenic lymphocytic cells comprising nucleotide sequences which code tumor, bacterial and or viral antigens for use as tools in delivering vaccines to disease bearing tissues; drug delivery
11/20/2008US20080286296 Cyclic-Dinucleotides and Its Conjugates as Adjuvants and Their Uses in Pharmaceutical Compositions
11/20/2008US20080286295 Use of recombinant antigens to determine the immune status of an animal
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286286 Methods to Treat Disease States by Influencing the Signaling of Ox-40-Receptors and High Throughput Screening Methods for Identifying Substances Therefor
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286281 Cd25 binding molecules for the use in the treatment of manifestations of rejection in transplantation
11/20/2008US20080286271 Methods and Compositions for Modulating Tweak and Fn14 Activity
11/20/2008US20080286249 Use of mesenchymal stem cells for treating genetic diseases and disorders
11/20/2008US20080286248 Hiv Vif Mutants
11/20/2008US20080286245 Preparation of regulatory t cells using icam-1 co-stimulation
11/20/2008CA2687254A1 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
11/20/2008CA2686903A1 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
11/20/2008CA2686838A1 Modulators of cftr
11/20/2008CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008CA2686216A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
11/20/2008CA2680344A1 Humaneered anti-factor b antibody
11/20/2008CA2667297A1 Oligoribonucleotides and uses thereof
11/19/2008EP1992644A1 Antibodies against CCR4 and its fragments
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992622A1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
11/19/2008EP1992356A2 Rapamycin and IL-10 for the treatment of immune diseases
11/19/2008EP1991554A1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them
11/19/2008EP1991532A2 Compositions and methods for inhibition of the jak pathway
11/19/2008EP1991246A2 Treatment of development-related disorders
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008EP1675481B1 Synbiotic composition for infants
11/19/2008EP1613288B1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
11/19/2008EP1513553B1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
11/19/2008EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1417349B1 Novel molecular target for neurotoxicity
11/19/2008EP1373510B1 Mutant allergens
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008EP1123711B1 Attenuated toxins as adjuvants
11/19/2008EP0888120B1 Immunogenic hla binding peptide and its uses to treat hiv infection
11/19/2008EP0802921B1 Human pak65
11/19/2008CN101309934A 修饰的伴侣蛋白10 Modified chaperonin 10
11/19/2008CN101309707A Compositions comprising lipoxygenase inhibitors and cyclodextrin
11/19/2008CN101309706A Controlled drug release composition and drug releasing medical device
11/19/2008CN101309705A Preventive or therapeutic agent and method for immune disease
11/19/2008CN101309703A 抗cd3抗体组合物 Anti-cd3 antibody compositions
11/19/2008CN101307281A Ginseng-snake wine
11/19/2008CN101307279A Nourishing cordial and method for preparing same
11/19/2008CN101307109A Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use
11/19/2008CN101307095A T-cell epitope peptide
11/19/2008CN101307094A Novel nuclear factor ¿Ckappa B p65 subunit antagonizing polypeptide
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306191A Use of TLR2 ligand PGN in treating metabolism syndrome
11/19/2008CN101306159A Siberian solomonseal rhizome polysaccharide buccal tablets
11/19/2008CN101306133A Oral liquid for anti-AIDS
11/19/2008CN101306131A Duituizidian pill
11/19/2008CN101306116A Xinnaoqingyu decoction
11/19/2008CN101306115A Decoction for treating acute urticaria
11/19/2008CN101306097A Zengkangning tablets quality control method
11/19/2008CN101306096A Decoction for treating chronic eczema
11/19/2008CN101306019A Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
11/19/2008CN101306018A Hyper-concentrated placenta tissue hydrolysate freeze-drying capsules and its preparation method
11/19/2008CN101306017A Hyper-concentrated placenta lipopolysaccharide freeze-drying capsules and its preparation method
11/19/2008CN101306005A Immunity enhancing medical nucleotide composition and its use in preparing immunosuppressive drug
11/19/2008CN101306004A Immunosuppression medical nucleotide composition and its use in preparing immunosuppressive medicament
11/19/2008CN101305975A Health preservation feet bath bag
11/19/2008CN101305827A Gadol beverage and its preparation method
11/19/2008CN101305826A Sparassis crsipa beverage
11/19/2008CN101305801A Dendrobium nobile American ginseng capsule
11/19/2008CN101305777A Gingko pulp paste
11/19/2008CN100434437C Biological active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine
11/19/2008CN100434428C Furazanobenzimidazoles
11/19/2008CN100434118C Application of cysteamine and its derivative in preparing medicine for raising potency of vaccine antibody
11/19/2008CN100434076C Compounding prepn. contg. cefteram pivoxil and pidotimod
11/18/2008US7452982 An immunogenic complex characterised in that an enzyme is integrated into an immunostimulating complex (ISCOM) containing a glycoside, a lipid and an antigen
11/18/2008US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452890 Substituted pyrazoles
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452879 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008US7452557 Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences
11/18/2008CA2469369C Compositions containing both sedative and non-sedative antihistamines
11/18/2008CA2452530C Novel immunosuppressive agent
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
1 ... 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 ... 1172